4
Changes in Ownership
VERTEX PHARMACEUTICALS INC / MA Filed Acc 0000875320-24-000152
EVP, COO sold 69 shares at $430.93 ($29,734)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Arbuckle Stuart A · EVP, COO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-05-15 | Sale : show line 1 in the form 10b5-1 | −69 | $430.93 | $29,734 | 49,691 | D |
| Open-market sales · 69 sh · avg $430.93 · $29,734 | ||||||
Loading xslF345X05/wk-form4_1715977463.xml…